160 related articles for article (PubMed ID: 29429048)
1. Peptide YY Causes Apathy-Like Behavior via the Dopamine D2 Receptor in Repeated Water-Immersed Mice.
Yamada C; Mogami S; Kanno H; Hattori T
Mol Neurobiol; 2018 Sep; 55(9):7555-7566. PubMed ID: 29429048
[TBL] [Abstract][Full Text] [Related]
2. The gut hormone peptide YY regulates appetite.
Batterham RL; Bloom SR
Ann N Y Acad Sci; 2003 Jun; 994():162-8. PubMed ID: 12851312
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
4. Peptide YY induces characteristic meal patterns of aged mice.
Mogami S; Yamada C; Fujitsuka N; Hattori T
Horm Behav; 2017 Nov; 96():62-68. PubMed ID: 28916138
[TBL] [Abstract][Full Text] [Related]
5. Gut hormone PYY(3-36) physiologically inhibits food intake.
Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR
Nature; 2002 Aug; 418(6898):650-4. PubMed ID: 12167864
[TBL] [Abstract][Full Text] [Related]
6. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
7. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice.
Rahardjo GL; Huang XF; Tan YY; Deng C
Endocrinology; 2007 Oct; 148(10):4704-10. PubMed ID: 17615145
[TBL] [Abstract][Full Text] [Related]
8. Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging.
Hankir MK; Parkinson JR; Minnion JS; Addison ML; Bloom SR; Bell JD
J Neuroendocrinol; 2011 Apr; 23(4):371-80. PubMed ID: 21251093
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice.
Painsipp E; Köfer MJ; Farzi A; Dischinger US; Sinner F; Herzog H; Holzer P
Br J Pharmacol; 2013 Nov; 170(5):1014-26. PubMed ID: 23992467
[TBL] [Abstract][Full Text] [Related]
10. Duplication of neuropeptide Y and peptide YY in Nile tilapia Oreochromis niloticus and their roles in food intake regulation.
Yan P; Jia J; Yang G; Wang D; Sun C; Li W
Peptides; 2017 Feb; 88():97-105. PubMed ID: 27988351
[TBL] [Abstract][Full Text] [Related]
11. Peptide YY signaling in the lateral parabrachial nucleus increases food intake through the Y1 receptor.
Alhadeff AL; Golub D; Hayes MR; Grill HJ
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E759-66. PubMed ID: 26330345
[TBL] [Abstract][Full Text] [Related]
12. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
13. NPY2 receptor activation in the dorsal vagal complex increases food intake and attenuates CCK-induced satiation in male rats.
Huston NJ; Brenner LA; Taylor ZC; Ritter RC
Am J Physiol Regul Integr Comp Physiol; 2019 Apr; 316(4):R406-R416. PubMed ID: 30726118
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.
Shoblock JR; Welty N; Nepomuceno D; Lord B; Aluisio L; Fraser I; Motley ST; Sutton SW; Morton K; Galici R; Atack JR; Dvorak L; Swanson DM; Carruthers NI; Dvorak C; Lovenberg TW; Bonaventure P
Psychopharmacology (Berl); 2010 Feb; 208(2):265-77. PubMed ID: 19953226
[TBL] [Abstract][Full Text] [Related]
15. The Y2 receptor agonist PYY(3-36) increases the behavioural response to novelty and acute dopaminergic drug challenge in mice.
Stadlbauer U; Weber E; Langhans W; Meyer U
Int J Neuropsychopharmacol; 2014 Mar; 17(3):407-19. PubMed ID: 24131590
[TBL] [Abstract][Full Text] [Related]
16. Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.
Nishizawa N; Niida A; Adachi Y; Masuda Y; Kumano S; Yokoyama K; Asakawa T; Hirabayashi H; Amano N; Takekawa S; Ohtaki T; Asami T
Bioorg Med Chem Lett; 2017 Aug; 27(16):3829-3832. PubMed ID: 28684122
[TBL] [Abstract][Full Text] [Related]
17. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
Riediger T; Bothe C; Becskei C; Lutz TA
Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
[TBL] [Abstract][Full Text] [Related]
18. Feeding after fourth ventricular administration of neuropeptide Y receptor agonists in rats.
Corp ES; McQuade J; Krasnicki S; Conze DB
Peptides; 2001 Mar; 22(3):493-9. PubMed ID: 11287106
[TBL] [Abstract][Full Text] [Related]
19. Peptide YY and appetite control.
McGowan BM; Bloom SR
Curr Opin Pharmacol; 2004 Dec; 4(6):583-8. PubMed ID: 15525548
[TBL] [Abstract][Full Text] [Related]
20. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity.
Vrang N; Madsen AN; Tang-Christensen M; Hansen G; Larsen PJ
Am J Physiol Regul Integr Comp Physiol; 2006 Aug; 291(2):R367-75. PubMed ID: 16914421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
